How are Adderall (amphetamine and dextroamphetamine) withdrawal symptoms managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Adderall Withdrawal Symptoms

Adderall withdrawal symptoms are best managed in a supportive environment with symptomatic treatment for specific manifestations like agitation and sleep disturbance, while no specific medication is recommended for the withdrawal process itself. 1

Understanding Adderall Withdrawal

Adderall (amphetamine and dextroamphetamine) withdrawal occurs due to physical dependence that develops with repeated use. When discontinued, especially abruptly, withdrawal symptoms may emerge as the body adjusts to the absence of the stimulant.

Common Withdrawal Symptoms:

Physical symptoms:

  • Fatigue and excessive sleepiness
  • Increased appetite
  • Tremors
  • Muscle aches
  • Headaches
  • Diaphoresis (sweating)
  • Sleep disturbances

Psychological symptoms:

  • Irritability and agitation
  • Depression
  • Anxiety
  • Anhedonia (inability to feel pleasure)
  • Difficulty concentrating
  • Intense cravings for the drug

Management Protocol

1. Supportive Environment

  • Withdrawal from amphetamines is best undertaken in a supportive environment 1
  • For severe cases, consider inpatient monitoring, especially if there's risk of depression with suicidal ideation

2. Symptomatic Management

  • No specific medication is recommended for amphetamine withdrawal treatment 1
  • Relief of symptoms should be achieved with symptomatic medication for the withdrawal period:
    • For agitation: Consider short-acting benzodiazepines (with caution)
    • For sleep disturbance: Non-benzodiazepine sleep aids
    • For pain/headaches: NSAIDs or acetaminophen

3. Monitoring for Complications

  • Depression or psychosis can occur during withdrawal; these cases need close monitoring 1
  • Use the Clinical Opiate Withdrawal Scale (COWS) or similar tools to assess withdrawal severity 1
  • Monitor vital signs, particularly for hypertension during initial withdrawal phase

4. Psychosocial Support

  • Short duration psychosocial support using motivational principles should be offered 1
  • Individuals who don't respond to brief interventions should be referred for specialist assessment 1

Special Considerations

Depression and Suicidality

  • Monitor closely for emergence of depression during withdrawal
  • If depression or psychosis occurs, seek advice from relevant specialists 1

Physical Dependence vs. Addiction

  • Physical dependence is an expected response with extended stimulant use 1
  • Withdrawal symptoms typically resolve relatively quickly (3-7 days) 1
  • Important to distinguish physical dependence from addiction, which develops more gradually and requires chronic care 1

Tapering Approach

  • For patients with significant dependence, consider gradual tapering rather than abrupt discontinuation
  • Similar to benzodiazepine tapering, reducing the dose by approximately 25% every 1-2 weeks may help minimize withdrawal symptoms 2

When to Seek Specialist Help

  • Patients with:
    • History of withdrawal seizures
    • Significant psychiatric comorbidities
    • Concurrent substance use disorders
    • Unstable medical conditions
    • Failure to respond to initial management

Pitfalls to Avoid

  • Confusing withdrawal symptoms with recurrence of conditions for which Adderall was prescribed (e.g., ADHD)
  • Using dexamphetamine to treat stimulant withdrawal (not recommended) 1
  • Underestimating the psychological component of dependence
  • Failing to provide adequate psychosocial support during withdrawal

By following this structured approach to managing Adderall withdrawal, clinicians can help patients navigate this challenging process while minimizing discomfort and preventing complications.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Benzodiazepine Tapering Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.